6505--Metoprolol Succinate Tablets SA

The Department of Veterans Affairs National Acquisition Center is soliciting offers for Metoprolol Succinate Sustained Action (SA) Tablets to support the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The procurement covers eight line items of these cardiac medication tablets in four different strengths (25mg, 50mg, 100mg, and 200mg) and various package sizes ranging from 100 to 1,000 tablets per bottle. Offerors must maintain FDA current Good Manufacturing Practices (cGMP) compliance throughout the contract period and provide a unique 11-digit NDC number for their products. The solicitation was issued on September 18, 2025, with offers due by October 2, 2025, at 2:30 PM Central Time. Pricing must include a 0.5% Cost Recovery Fee and cover a base year plus four one-year option periods. One aggregate award will be made for all line items to a single contractor.

This procurement is set aside for small businesses despite being classified as unrestricted, indicating specific eligibility requirements for potential offerors. The estimated annual usage varies significantly across line items, ranging from approximately 9,666 bottles for lower-demand configurations to 164,458 bottles for higher-demand items, serving multiple federal agencies including the VA, DoD, Indian Health Service, and Bureau of Prisons. The contract structure includes a base performance period with four additional option years, potentially extending the total contract duration to five years. No incumbent contractor or current service provider is identified in the available documentation. The procurement falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals), reflecting the specialized nature of this pharmaceutical manufacturing requirement.